Agfa HealthCare Enterprise Imaging XERO Viewer
Recall Z-1004-2023, part of FDA recall event 91357. See Agfa HealthCare's company page.
Agfa Healthcare NV started this Class II device recall on Dec 5, 2022 (voluntary: firm initiated); FDA lists it as ongoing.
- Classification: Class II
- Started: Dec 5, 2022
- Status: Ongoing
There is a software defect that can cause issues with images.
- Product
- Agfa HealthCare Enterprise Imaging XERO Viewer
- Quantity
- 110 units
- Lots and codes
- Affected software versions include: XERO Viewer 8.1.4.100 or higher XERO Viewer 8.2.0.000 or higher XERO Viewer 8.2.1.000 or higher UDI/DI: 05400874000710
- Distribution
- Distribution throughout US OUS distribution to Australia, Belgium, Brazil, Canada, Chile, Cyprus, France, Iceland, Ireland, Italy, Kenya, Luxembourg, Netherlands, Romania, Saudi Arabia, Spain, Sweden, United Kingdom, South Africa
- Recalling firm
- Agfa Healthcare NV, Mortsel, N/A, Belgium
- How the firm notified
- Letter
- FDA classified
- Jan 20, 2023
Newest first, one product per recall event; search them all
- Enterprise Imaging XERO Viewer- software application used for reference and diagnostic viewing of multispecialtyโฆZ-0055-2025 ยท Class II ยท Sep 6, 2024 ยท Ongoing
- Enterprise Imaging Desktops Enterprise Imaging Desktops (Radiology Suite/Cardiology Suite) when deployed as aโฆZ-0101-2019 ยท Class II ยท Aug 3, 2018 ยท Terminated
FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA device enforcement reports